Literature DB >> 2702091

Measurement of erythropoietin in anephric children. A report of the Southwest Pediatric Nephrology Study Group.

B S Beckman1, J W Brookins, M M Garcia, J W Fisher.   

Abstract

Serum erythropoietin (Ep) levels were measured using a highly sensitive radioimmunoassay in 69 children undergoing chronic dialysis; 31 were anephric, whereas 38 were non-nephrectomized (nephric). Twenty-nine normal children were studied as controls. Serum Ep levels in the anephric group were much higher than anticipated (mean 19.7 +/- 1.8 mU/ml), albeit significantly lower than those measured in normal children (mean 26.2 +/- 2.4 mU/ml, P less than 0.05), or in nephric children on dialysis (33.0 +/- 2.9 mU/ml, P less than 0.001). Anephric children on peritoneal dialysis (PD) had significantly (P less than 0.05) higher serum levels of Ep (22.7 +/- 2.4 mU/ml, n = 19) than anephric children on hemodialysis (HD) (15.1 +/- 2.3 mU/ml, n = 12). There was no significant difference between Ep levels in anephric patients dialyzed for less than or equal to 1 year (19.6 +/- 2.0 mU/ml, n = 20) compared with anephric patients dialyzed for more than 1 year (20.0 +/- 3.9 mU/ml, n = 11). Although serum Ep levels showed a tendency to increase with time after nephrectomy, the mean values for less than 3 months (14.7 +/- 1.9), 3 months-12 months (21.0 +/- 2.7), and greater than 12 months (21.6 +/- 6.0) were not significantly different from each other. This demonstration of relatively normal levels of serum Ep in anephric children suggests that extrarenal sites of Ep production are able to exert a significant response to severe anemia in patients who are devoid of renal parenchyma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2702091     DOI: 10.1007/BF00859630

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  17 in total

Review 1.  Extrarenal erythropoietin production.

Authors:  J W Fisher
Journal:  J Lab Clin Med       Date:  1979-05

2.  Extrarenal erythropoietin production.

Authors:  J W Fisher; W J Stuckey; D D Lindholm; S Abshire
Journal:  Isr J Med Sci       Date:  1971 Jul-Aug

3.  Erythropoietin alterations in patients with uremia, renal allografts, or without kidneys.

Authors:  E A Mirand; G P Murphy
Journal:  JAMA       Date:  1969-07-21       Impact factor: 56.272

Review 4.  Hematologic disorders in renal failure.

Authors:  J P Naets
Journal:  Nephron       Date:  1975       Impact factor: 2.847

Review 5.  The role of erythropoietin in the anemia of chronic renal failure.

Authors:  N K Krane
Journal:  Henry Ford Hosp Med J       Date:  1983

6.  Uremia and the liver. I. The liver and erythropoiesis in chronic renal failure.

Authors:  A Meyrier; P Simon; G Boffa; P Brissot
Journal:  Nephron       Date:  1981       Impact factor: 2.847

7.  Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates.

Authors:  P M Cotes
Journal:  Br J Haematol       Date:  1982-03       Impact factor: 6.998

8.  Serum erythropoietin levels in children with chronic renal failure.

Authors:  D E Müller-Wiefel; K Schärer
Journal:  Kidney Int Suppl       Date:  1983-11       Impact factor: 10.545

9.  A radioimmunoassay for erythropoietin: serum levels in normal human subjects and patients with hemopoietic disorders.

Authors:  A B Rege; J Brookins; J W Fisher
Journal:  J Lab Clin Med       Date:  1982-12

10.  Effect of different modes of dialysis on serum erythropoietin levels in pediatric patients. A report of the Southwest Pediatric Nephrology Study Group.

Authors:  B S Beckman; J W Brookins; R K Shadduck; K F Mangan; L J Deftos; J W Fisher
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

View more
  1 in total

Review 1.  Trials and tribulations of multicenter studies. Lessons learned from the experiences of the Southwest Pediatric Nephrology Study Group (SPNSG).

Authors:  R J Hogg
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.